414 related articles for article (PubMed ID: 22083089)
1. The multifactorial role of leptin in driving the breast cancer microenvironment.
Andò S; Catalano S
Nat Rev Endocrinol; 2011 Nov; 8(5):263-75. PubMed ID: 22083089
[TBL] [Abstract][Full Text] [Related]
2. Leptin-cytokine crosstalk in breast cancer.
Newman G; Gonzalez-Perez RR
Mol Cell Endocrinol; 2014 Jan; 382(1):570-582. PubMed ID: 23562747
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted leptin network: the molecular connection between obesity and breast cancer.
Saxena NK; Sharma D
J Mammary Gland Biol Neoplasia; 2013 Dec; 18(3-4):309-20. PubMed ID: 24214584
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.
Guo S; Liu M; Wang G; Torroella-Kouri M; Gonzalez-Perez RR
Biochim Biophys Acta; 2012 Apr; 1825(2):207-22. PubMed ID: 22289780
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer and obesity: in vitro interferences between adipokines and proangiogenic features and/or antitumor therapies?
Dubois V; Delort L; Billard H; Vasson MP; Caldefie-Chezet F
PLoS One; 2013; 8(3):e58541. PubMed ID: 23554900
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis, adipokines and breast cancer.
Vona-Davis L; Rose DP
Cytokine Growth Factor Rev; 2009 Jun; 20(3):193-201. PubMed ID: 19520599
[TBL] [Abstract][Full Text] [Related]
7. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
[TBL] [Abstract][Full Text] [Related]
8. Leptin signaling in breast cancer: an overview.
Cirillo D; Rachiglio AM; la Montagna R; Giordano A; Normanno N
J Cell Biochem; 2008 Nov; 105(4):956-64. PubMed ID: 18821585
[TBL] [Abstract][Full Text] [Related]
9. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression.
He JY; Wei XH; Li SJ; Liu Y; Hu HL; Li ZZ; Kuang XH; Wang L; Shi X; Yuan ST; Sun L
Cell Commun Signal; 2018 Dec; 16(1):100. PubMed ID: 30563531
[TBL] [Abstract][Full Text] [Related]
10. Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion.
Li K; Wei L; Huang Y; Wu Y; Su M; Pang X; Wang N; Ji F; Zhong C; Chen T
Int J Oncol; 2016 Jun; 48(6):2479-87. PubMed ID: 27082857
[TBL] [Abstract][Full Text] [Related]
11. Peritumoral expression of adipokines and fatty acids in breast cancer.
Gnerlich JL; Yao KA; Fitchev PS; Goldschmidt RA; Bond MC; Cornwell M; Crawford SE
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S731-8. PubMed ID: 24052317
[TBL] [Abstract][Full Text] [Related]
12. The biology of leptin and its implications in breast cancer: a general view.
García-Robles MJ; Segura-Ortega JE; Fafutis-Morris M
J Interferon Cytokine Res; 2013 Dec; 33(12):717-27. PubMed ID: 23869900
[TBL] [Abstract][Full Text] [Related]
13. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
[TBL] [Abstract][Full Text] [Related]
14. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
Khan S; Shukla S; Sinha S; Meeran SM
Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
[TBL] [Abstract][Full Text] [Related]
15. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
[TBL] [Abstract][Full Text] [Related]
16. Growth of breast cancer cells by leptin is mediated via activation of the inflammasome: Critical roles of estrogen receptor signaling and reactive oxygen species production.
Raut PK; Kim SH; Choi DY; Jeong GS; Park PH
Biochem Pharmacol; 2019 Mar; 161():73-88. PubMed ID: 30633869
[TBL] [Abstract][Full Text] [Related]
17. Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.
Giordano C; Barone I; Vircillo V; Panza S; Malivindi R; Gelsomino L; Pellegrino M; Rago V; Mauro L; Lanzino M; Panno ML; Bonofiglio D; Catalano S; Andò S
Sci Rep; 2016 Feb; 6():21782. PubMed ID: 26899873
[TBL] [Abstract][Full Text] [Related]
18. The Leptin Axis and Its Association With the Adaptive Immune System in Breast Cancer.
García-Estevez L; González-Martínez S; Moreno-Bueno G
Front Immunol; 2021; 12():784823. PubMed ID: 34868066
[TBL] [Abstract][Full Text] [Related]
19. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
20. Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis.
Uddin S; Hussain AR; Khan OS; Al-Kuraya KS
Tumour Biol; 2014 Feb; 35(2):871-9. PubMed ID: 24014051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
